Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
Go back to Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study| (NASDAQ: LEXX) | Delayed: 3.22 +0.30 (10.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.92 | 52 Week High | $ | |||
| Open | $2.91 | 52 Week Low | $ | |||
| Day High | $3.31 | P/E | N/A | |||
| Day Low | $2.91 | EPS | $ | |||
| Volume | 43,069 | |||||



